• CDC's independent valuation increased by 23.6% to A$18.5 billion
• Infratil's 49.72% interest in CDC valued at A$9.2 billion
• Valuation driven by growth in contracted capacity and expansion of pipeline

Infratil Ltd announced that CDC's independent valuation increased by 23.6% during the quarter to a mid-point of A$18.5 billion as of 30 June 2026. This increase was driven by strong growth in CDC's contracted capacity, which surpassed 1GW, the acceleration of CDC's build program to support this demand, and the expansion of CDC's total pipeline to FY40 from 2.6GW to 3.9GW of leasable capacity to support future growth. The 30 June 2026 independent valuation of CDC increased by A$3.5 billion from 31 March 2026 to A$18.5 billion, reflecting the mid-point of the assessed valuation range of A$17.5 billion to A$19.7 billion. On this basis, the independent valuation of Infratil's 49.72% interest in CDC is A$9,213 million, up A$1,759 million from A$7,454 million at 31 March 2026. Further valuation details are included in the attached presentation document.

CDC's independent valuation increased by 23.6% to A$18.5 billion by 30 June 2026

CDC's continued investment in the long-term pipeline will ensure it maintains sufficient runway to capture ongoing customer demand.